Cefdinir vs. amoxicillin/clavulanic acid in the treatment of suppurative acute otitis media in children

M. Adler, P. J. McDonald, U. Trostmann, C. Keyserling, K. Tack

    Research output: Contribution to journalArticlepeer-review

    21 Citations (Scopus)

    Abstract

    An investigator-blinded, randomized, multicenter study was conducted to compare the efficacy and safety of cefdinir and amoxicillin/clavulanate (amoxicillin/CA) in the treatment of pediatric patients with acute suppurative otitis media. Patients 6 months to 12 years of age were randomized in a 1:1:1 ratio to receive cefdinir 14 mg/kg once-daily, cefdinir 7 mg/kg b.i.d., or amoxicillin/CA 13.3 mg/kg t.i.d. Test-of-cure was determined 11 to 16 days posttherapy. Of the 752 patients who entered the study, 665 (88%) completed treatment and 595 (79%) were evaluable. Response rates in the three treatment groups were similar. Overall rates of adverse events were statistically lower in the cefdinir once-daily group than in the amoxicillin/CA group. Diarrhea was the most common adverse event in all treatment groups. Cefdinir given either once-daily or twice-daily is a safe and effective treatment for pediatric patients with acute suppurative otitis media.

    Original languageEnglish
    Pages (from-to)S166-S170
    Number of pages5
    JournalPediatric Infectious Disease Journal
    Volume19
    Issue number12 SUPPL.
    DOIs
    Publication statusPublished - Dec 2000

    Keywords

    • Amoxicillin/clavulanic acid
    • Cefdinir
    • Children
    • Suppurative acute otitis media

    Fingerprint Dive into the research topics of 'Cefdinir vs. amoxicillin/clavulanic acid in the treatment of suppurative acute otitis media in children'. Together they form a unique fingerprint.

    Cite this